搜索结果: 'methocult media formulations for human hematopoietic cells serum containing'

Expression of a human beta-globin transgene in erythroid cells derived from retrovirally transduced transplantable human fetal liver and cord blood cells.

Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells

Creation of human cardiac cell sheets using pluripotent stem cells

ImmunoCult™ 人CD3/CD28/CD2 T细胞激活剂 人T细胞激活扩增试剂

Human pluripotent stem cells: from biology to cell therapy.

Feeder-independent culture of human embryonic stem cells.

Characterization and evaluation of human embryonic stem cells.

Therapeutic Application of Endothelial Colony-Forming Cells for Retinal Diseases In this webinar, Drs. Susumu Sakimoto and Valentina Marchetti discuss their current research on generating human endothelial colony-forming cells (ECFCs) under xeno-free conditions to treat vascular abnormalities in the eye. Vascular abnormalities are a common component of eye diseases that often lead to vision loss. It is possible to use one cell type to rescue another cell type in the face of severe stress. Dr. Susumu will present his study on how human ECFCs injected into the vitreous cavity rescue vaso-obliteration and neurodegeneration in animal models of retinal disease. These results help us understand the mechanism of ECFC-based therapies for ischemic insults and retinal neurodegenerative diseases. Dr. Valentina Marchetti will present a workflow to derive and expand ECFCs under xeno-free conditions using the EC-Cult™-XF ECFC Culture Kit.

STEMdiff™ Neural Induction Medium Versus STEMdiff™ SMADi Neural Induction Kit Technical tip from our dedicated team of Product and Scientific Support specialists

人脐带血质量控制试剂盒 造血集落测定质量控制试剂盒

Re-Creating Disease with Kidney Organoids and CRISPR In this webinar, Dr. Benjamin Freedman from the University of Washington provides an overview of re-creating disease using kidney organoids and CRISPR-Cas9 genome editing. As a postdoctoral fellow in the Renal Division at Brigham and Women’s Hospital at Harvard Medical School, Dr. Freedman was responsible for several innovative techniques that he describes in this webinar, including differentiation of human pluripotent stem cells (hPSCs) into kidney organoids containing nephron-like segments and generating knockout mutations in organoids with CRISPR.

Immunomagnetic Cell Isolation of Untouched Human Regulatory T Cells .